Biodesix Inc
Research Biodesix Inc (BDSX) on Bullrun: market cap USD 240.65M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBDSX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 240.65M
- Financial periodFY2025
- RevenueUSD 88.50M
- Revenue growth24.1%
- Net income-USD 35.27M
- Free cash flow-USD 23.53M
Valuation Snapshot
latest market cap is USD 240.65M.
About Biodesix Inc
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules.
Frequently asked questions
What is Biodesix Inc's market cap?
Biodesix Inc's market capitalization is USD 240.65M.
What does Biodesix Inc do?
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help...